热反应性碳金释放前药物
Aemilia D McAdam1, Lucinda K Batchelor1, Jan Romano-deGea1
1Institute of Chemical Sciences and Engineering, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Journal of inorganic biochemistry
|February 20, 2024
概括
新的 (IV) 碳原前药在癌症治疗方面显示出前景. 这些新型化合物通过轻度高温激活,减少副作用并提高卵巢癌治疗的疗效.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
背景情况:
- 基于白金的化疗,包括碳白金,是有效的,但会引起严重的副作用.
- 热量过高是一种有益的辅助癌症疗法,但现有的白金药物对其没有优化.
- 针对瘤部位的药物激活可以改善治疗指数.
研究的目的:
- 为了合成和表征新的 (IV) 碳原前药物.
- 研究这些前药物在卵巢癌细胞中的热敏性和细胞毒性.
- 探讨 perfluorinated 链条长度对药物激活和疗效的影响.
主要方法:
- 合成单替代和二替代 (((IV) 碳烯原药与化链.
- 在37°C和42°C的卵巢癌细胞系上细胞毒性的体外评估.
- 使用核磁共振 (NMR) 谱学和质谱学进行表征.
- 使用循环电压计进行电化学分析.
主要成果:
- 成功合成了一系列 (IV) 碳原前药物.
- 已证明的热敏性:前药物在37°C处无活性,但在42°C处活跃.
- 在42°C的温度下,其活性与原始碳烯相美.
- perfluorinated 链条长度显著影响碳烯的释放速度和细胞毒性.
结论:
- 开发了新的热敏 (IV) 碳原前药物.
- 这些前期药物有潜力通过高热度进行向癌症治疗,最大限度地降低全身毒性.
- 药物设计包含化链,提供了一种控制制药释放和活性的机制.
相关概念视频
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
290
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
290


